Compound preparation of montmorillonite

A compound preparation and montmorillonite technology, applied in the field of medicine, can solve the problems of increasing production cost, complicated process and the like, and achieve the effects of orderly arrangement, uniform distribution and low direct toxicity.

Inactive Publication Date: 2012-02-01
JINAN KANGZHONG PHARMA TECH DEV
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The process is cumbersome and increases the production cost

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound preparation of montmorillonite
  • Compound preparation of montmorillonite
  • Compound preparation of montmorillonite

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0075] Take 1000g of montmorillonite, 94g of zinc citrate, and 100g of sucrose powder, and mix them thoroughly to obtain a powder. This compound medicine, montmorillonite: zinc=1: 0.03.

Embodiment 2

[0077] Take 1000g of montmorillonite and 200g of licorice zinc, mix well, wet granulate, dry, granulate, add an appropriate amount of lubricant, mix evenly, compress into tablets to obtain dispersible tablets. This compound medicine, montmorillonite: zinc=1: 0.01.

Embodiment 3

[0079] Take 1000g of montmorillonite, 33.5g of zinc chloride and 2g of sodium saccharin powder, and mix well to obtain a powder. This compound drug, montmorillonite: zinc = 1: 0.0016

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a compound preparation of montmorillonite. The compound preparation is characterized by being prepared by adding a zinc salt into montmorillonite, wherein the weight ratio of the montmorillonite to the zinc salt is 1:(0.0016-0.044). The compound preparation is used for treating diarrhea, peptic ulcer and zinc deficiency, and has the advantages of no side effects, simple production process and good effects for treating diarrhea, peptic ulcer and zinc deficiency.

Description

field of invention [0001] The invention relates to medicines, in particular to a compound preparation of montmorillonite, which belongs to the field of medicines. Background of the invention [0002] Diarrhea, peptic ulcer and zinc deficiency are common and frequently-occurring diseases. [0003] WHO and UNICEF have jointly published a newly revised recommended guideline for the management of diarrhea, which was supported by the United States Agency for International Development and many experts around the world. The research results: ① The new ORS formula containing lower concentrations of glucose and NaCl can help shorten the duration of diarrhea, reduce the amount of stool and reduce intravenous fluid rehydration; Afterwards, zinc supplementation is required. Zinc supplementation is beneficial to shorten the course of diarrhea, alleviate the condition and prevent the recurrence of diarrhea in the next 2-3 months. [0004] Zinc preparations are often used to treat peptic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61P1/04A61K33/06A61K33/30A61K31/704A61K9/14A61P3/12A61K31/194A61K31/191A61K31/197A61K9/20A61P1/12A61K31/19
Inventor 张为胜李诗标周长征牛凤菊徐翠萍
Owner JINAN KANGZHONG PHARMA TECH DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap